The main aim of this WP is to systematically characterise the effect of the early-life exposome, repeatedly assessed over time, on health outcomes in adolescence. The WP builds upon the ATHLETE cohorts with a follow-up until adolescence between 12-18 years of age, with longitudinal individual information on the external and personal exposome and health outcomes (BiB, EDEN, INMA, KANC, MoBa, Rhea, Gen R, NINFEA, PÉLAGIE, and DNBC).
We will focus on:
- Cognition, behaviour and mental health
- Cardio-metabolic health and obesity
- Respiratory health, allergies and asthma
- Multiple health outcomes